Tower Research Capital LLC (Trc) A Tyr Pharma Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 13,540 shares of LIFE stock, worth $25,184. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,540

Previous 27,338 50.47%

Holding current value

$25,184

Previous $42,000 40.48%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.24 $20,834 - $30,907	-13,798 Reduced 50.47%	13,540 $25,000
Q2 2024 Aug 13, 2024	BUY	$0.0 - $2.07 $0 - $43,616	21,071 Added 336.22%	27,338 $42,000
Q1 2024 May 15, 2024	BUY	$1.42 - $2.02 $8,899 - $12,659	6,267 New	6,267 $12,000
Q3 2023 Nov 14, 2023	BUY	$1.55 - $2.23 $730 - $1,050	471 Added 223.22%	682 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.72 - $2.57 $1,840 - $2,749	-1,070 Reduced 83.53%	211 $0
Q1 2023 May 09, 2023	SELL	$1.88 - $2.5 $30,384 - $40,405	-16,162 Reduced 92.66%	1,281 $3,000
Q4 2022 Feb 10, 2023	SELL	$2.02 - $2.49 $47,514 - $58,569	-23,522 Reduced 57.42%	17,443 $38,000
Q3 2022 Nov 10, 2022	BUY	$2.79 - $4.15 $53,428 - $79,472	19,150 Added 87.78%	40,965 $123,000
Q2 2022 Aug 15, 2022	BUY	$2.63 - $5.61 $54,682 - $116,643	20,792 Added 2032.45%	21,815 $62,000
Q1 2022 May 12, 2022	BUY	$4.75 - $7.54 $4,740 - $7,524	998 Added 3992.0%	1,023 $5,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $4,782 - $6,232	-656 Reduced 96.33%	25 $0
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $2,080 - $6,152	493 Added 262.23%	681 $6,000
Q2 2021 Aug 16, 2021	SELL	$3.62 - $4.88 $54,528 - $73,507	-15,063 Reduced 98.77%	188 $1,000
Q1 2021 May 17, 2021	BUY	$3.53 - $8.06 $43,817 - $100,048	12,413 Added 437.39%	15,251 $68,000
Q4 2020 Feb 16, 2021	BUY	$3.07 - $4.66 $5,584 - $8,476	1,819 Added 178.51%	2,838 $11,000
Q3 2020 Nov 16, 2020	BUY	$3.23 - $5.39 $3,291 - $5,492	1,019 New	1,019 $4,000
Q1 2020 May 15, 2020	SELL	$2.17 - $7.06 $3,919 - $12,750	-1,806 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$3.03 - $4.83 $12,668 - $20,194	-4,181 Reduced 69.83%	1,806 $8,000
Q3 2019 Nov 05, 2019	BUY	$2.8 - $5.46 $16,763 - $32,689	5,987 New	5,987 $21,000

Others Institutions Holding LIFE

# of Institutions

Shares Held

37.1M

Call Options Held

30.2K

Put Options Held

3.1K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) A Tyr Pharma Inc Transaction History